Surgeries and Endoscopic Procedures Offer Different Benefits for MASLD

JCI MASLD in children: integrating epidemiological trends with mechanistic and translational advances

Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common pediatric liver disease, affecting approximately 10% of children. Its prevalence is rising at an alarming rate, with cases increasingly identified even in early childhood. While MASLD shares key features across the lifespan, its earlier onset reflects developmental vulnerabilities and unique mechanistic drivers. Perinatal influences, including maternal obesity, g…

Surgeries and Endoscopic Procedures Offer Different Benefits for MASLD

Researchers said longitudinal studies are critical to refine and optimize the management of metabolic dysfunction–associated steatotic liver disease (MASLD).